Ken Griffin Eli Lilly & CO Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $193 Million - $240 Million	249,500 Added 20.93%	1,441,700 $1.28 Billion
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $174 Million - $218 Million	-240,000 Reduced 16.76%	1,192,200 $1.08 Billion
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $96.2 Million - $129 Million	-162,500 Reduced 10.19%	1,432,200 $1.11 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $124 Million - $146 Million	235,300 Added 17.31%	1,594,700 $930 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $19.5 Million - $26.9 Million	44,900 Added 3.42%	1,359,400 $730 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $196 Million - $262 Million	557,600 Added 73.67%	1,314,500 $616 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $191 Million - $224 Million	-614,800 Reduced 44.82%	756,900 $260 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $357 Million - $416 Million	-1,110,100 Reduced 44.73%	1,371,700 $502 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $483 Million - $550 Million	1,629,100 Added 191.05%	2,481,800 $802 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.